Antifungal activity of micafungin in serum

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 10, 2009, Pages 4559-4562

  Ishikawa, Jun ^a   Maeda, Tetsuo ^a   Matsumura, Itaru ^a   Yasumi, Masato ^a   Ujiie, Hidetoshi ^a   Masaie, Hiroaki ^a   Nakazawa, Tsuyoshi ^a   Mochizuki, Nobuo ^b   Kishino, Satoshi ^b   Kanakura, Yuzuru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICAFUNGIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIFUNGAL ACTIVITY; ARTICLE; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; BROTH DILUTION; CLINICAL ARTICLE; DISK DIFFUSION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LYMPHOMA; MALE; MAXIMUM PLASMA CONCENTRATION; MYCOSIS; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROPHYLAXIS; SERUM; TREATMENT DURATION;

ADULT; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ECHINOCANDINS; FEMALE; HUMANS; LIPOPEPTIDES; MALE; MIDDLE AGED; SERUM; YOUNG ADULT;

EID: 70349317373     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01404-08     Document Type: Article

References (13)

1. Ascioglu, S., J. H. Rex, B. de Pauw, J. E. Bennett, J. Bille, F. Crokaert, D. W. Denning, J. P. Donnelly, J. E. Edwards, Z. Erjavec, D. Fiere, O. Lortholary, J. Maertens, J. F. Meis, T. F. Patterson, J. Ritter, D. Selleslag, P. M. Shah, D. A. Stevens, and T. J. Walsh, the Invasive Fungal Infections Cooperating Group of the European Organization for Research and Treatment of Cancer, and Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7-14.
2. Azuma, J., K. Nakahara, A. Kagayama, T. Kajiho, A. Kawamura, H. Suematsu, and T. Mukai. 2002. Phase I study of micafungin. Jpn. J. Chemother. 50(Suppl. 1):104-147.
3. Maki, K., S. Matsumoto, E. Watabe, Y. Iguchi, M. Tomishima, H. Ohki, A. Yamada, F. Ikeda, S. Tawara, and S. Mutoh. 2008. Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds. Microbiol. Immunol. 52:383-391.
4. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A2. NCCLS, Wayne, PA.
5. National Committee for Clinical Laboratory Standards. 2004. Method for antifungal disc diffusion susceptibility testing of yeasts: proposed guideline M44-A. NCCLS, Wayne, PA.
6. Odabasi, Z., V. Paetznick, J. H. Rex, and L. Ostrosky-Zeichner. 2007. Effects of serum on in vitro susceptibility testing of echinocandins. Antimicrob. Agents Chemother. 51:4214-4216.
7. Paderu, P., G. Garcia-Effron, S. Balashov, G. Delmas, S. Park, and S. Perlin. 2007. Serum differentially alters the antifungal properties of echinocandin drugs. Antimicrob. Agents Chemother. 51:2253-2256.
8. Schäfer-Korting, M., H. C. Korting, W. Rittler, and W. Obermüller. 1995. Influence of serum protein binding on the in vitro activity of antifungal agents. Infection 23:292-297.
9. Tabata, K., M. Katashima, A. Kawamura, Y. Tanigawara, and K. Sunagawa. 2006. Linear pharmacokinetics of micafungin and its active metabolites in Japanese pediatric patients with fungal infections. Biol. Pharm. Bull. 29:1706-1711.
10. Tamura, K., A. Urabe, M. Yoshida, A. Kanamaru, Y. Kodera, S. Okamoto, S. Maesaki, and T. Masaoka. 2008. Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders. Leuk. Lymphoma 50:92-100.
11. Tawara, S., F. Ikeda, K. Maki, Y. Morishita, K. Otomo, N. Teratani, T. Goto, M. Tomishima, H. Ohki, A. Yamada, K. Kawabata, H. Takasugi, K. Sakane, H. Tanaka, F. Matsumoto, and S. Kuwahara. 2000. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob. Agents Chemother. 44:57-62.
12. Yamato, Y., H. Kaneko, K. Tanimoto, M. Katashimaet, K. Ishibashi, A. Kamamura, M. Terakawa, and A. Kagayama. 2002. Simultaneous determination of antifungal drug, micafungin, and its two active metabolites in human plasma using high-performance liquid chromatography with fluorescence detection. Jpn. J. Chemother. 50(Suppl. 1):68-73.
13. Yamato, Y., H. Kaneko, T. Hashimoto, M. Katashima, K. Ishibashi, A. Kawamura, M. Terakawa, and A. Kagayama. 2002. Pharmacokinetics of the antifungal drug micafungin in mice, rats and dogs, and its in vitro protein binding and distribution to blood cells. Jpn. J. Chemother. 50(Suppl. 1):74-79.